Ardent Health, Inc.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-09-30; filed 2024-11-07.
0001756655-24-000017
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2025-03-31; filed 2025-05-07.
0001628280-25-023210
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 30 previous paragraphs and 7 current paragraphs.
3 unchanged; 1 reworded; 3 added; 26 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 2 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes to our risk factors that we believe are material to our business, results of operations and
Added paragraphs (3)
Current report
Report, which are incorporated by reference herein.
Current report
During thethree months ended March 31, 2025, we made the following purchases of our equity securities that are registered
Current report
pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Removed paragraphs (26)
Previous report
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Previous report
(a) Recent Sales of Unregistered Securities
Previous report
On July 17, 2024, in connection with the IPO, ALH Holdings, LLC (a subsidiary of Ventas, Inc.) contributed all of its
Previous report
outstanding common stock in AHP Health Partners (our direct subsidiary) to Ardent Health Partners, Inc. in exchange for
Previous report
5,178,202 shares of common stock of Ardent Health Partners, Inc. (the “ALH Contribution”). The issuance of securities in
Previous report
the ALH Contribution was deemed to be exempt from registration under the Securities Act of 1933, as amended, pursuant to
Previous report
Section 4(a)(2) thereof, as a transaction by an issuer not involving any public offering.
Previous report
(b) Use of Proceeds from Initial Public Offering of Common Stock
Previous report
On July 17, 2024, our registration statement on Form S-1 (File No. 333-280425) related to the IPO was declared effective by
Previous report
the SEC. Pursuant to such registration statement, we issued and sold 12,000,000 shares of common stock at a public offering
Previous report
price of $16.00 per share on July 19, 2024. We received net proceeds of approximately$181.4 million, after deducting
Previous report
underwriting discounts and commissions of approximately$10.6 million. On July 30, 2024, in conjunction with the
Previous report
underwriters exercising their option to purchase additional shares, we issued an additional 1,800,000 shares of common stock
Previous report
at the initial public offering price of $16.00 per share for additional net proceeds of approximately$27.2 million, after
Previous report
deducting underwriting discounts and commissions of approximately$1.6 million. None of the expenses associated with the
Previous report
IPO were paid to directors, officers, or persons owning 10% or more of any class of equity securities, or to our affiliates.
Previous report
There has been no material change in the planned use of proceeds from the IPO from those described in the Final Prospectus,
Previous report
dated July 17, 2024, filed with the SEC on July 18, 2024, pursuant to Rule 424(b) of the Securities Act. J.P. Morgan
Previous report
Securities LLC, BofA Securities, Inc. and Morgan Stanley & Co. LLC acted as joint book-running managers for the IPO. For
Previous report
additional details on the IPO, refer to Note 1 “Description of the Business and Basis of Presentation—Initial Public Offering
Previous report
and Corporate Conversion”in the notes to the unaudited condensed consolidated financial statements included elsewhere in
Previous report
this Quarterly Report.
Previous report
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Reworded paragraphs (1)
Previous wording
financial condition from the risk factors previously disclosed in the section entitled “Risk factors” included in the Final
Current wording
financial condition from the risk factors previously disclosed in the section entitled “Risk Factors” included in the Annual